What are the monoclonal antibodies Trump received?
33:23
(CNN) -
Pharmacist Eli Lilly said Tuesday that it has put its trial of a combination coronavirus antibody treatment on hold for safety reasons.
Clinical trials are usually stopped because a volunteer has suffered a side effect or gotten sick, but the company did not say what happened.
"Safety is of the utmost importance to Lilly," a spokesperson told CNN by email.
Johnson & Johnson pauses coronavirus vaccine trial after 'unexplained illness'
The company said the trial's Data Security Monitoring Board (DSMB), an independent group of medical experts that monitors clinical trials, had recommended the pause.
“The trial, which evaluates the neutralizing antibody in Lilly's research as a treatment for COVID-19 in hospitalized patients, is sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH).
Lilly supports the independent DSMB's decision to cautiously ensure the safety of the patients participating in this study, ”the company said in the statement.
Lilly is testing a combination of two laboratory-engineered immune system proteins called monoclonal antibodies to treat seriously ill patients with coronavirus.
Regeneron's cocktail of antibodies against covid-19, a hope for infected people, according to the pharmaceutical company
It is similar to the Regeneron treatment used by US President Donald Trump earlier this month.
